InvestorsHub Logo
icon url

scottsmith

01/09/17 1:18 PM

#167785 RE: runninggirl2016 #167782

Oh, sister!
icon url

Jhawker

01/09/17 1:27 PM

#167789 RE: runninggirl2016 #167782

Again it's our riskiest candidate. Many trials which equals time money and hurdles. Oncology trials are always risky.
icon url

NotRichYet2

01/09/17 1:30 PM

#167791 RE: runninggirl2016 #167782

Agree - and that PHASE I trial was extended some because it was doing so well and DANA FARBER is the type of institution to do that to confirm.